Status: Recruiting
Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers
Prospective screening study at Odense University Hospital to assess the effect of transient elastography and other serum and imaging markers of liver fibrosis to detect advanced fibrosis (Kleiner Fibrosis score F3-F4) in patients at risk of non-alcoholic fatty liver disease, alcoholic fatty liver disease, with a control group of participants recruited from the general population.
Participants needed: 6,500
Trial details
Age: 30-75Biological sex: AllType: InterventionalSponsor: Maja ThieleUpdated: Sep 1, 2022Locations: 1
Eligibility criteria
Age 30-75 years (except the general population, which should be aged 40-75) [+5]
Evidence of decompensated liver disease, defined by clinically obvious ascites,... [+7]